Daniel Rabinowitz sold $791K of Natera (NTRA)

Executed Jan 29 2025, disclosed Jan 31 2025, 2 days later.

Value, as filed

$791K

4,771 sh across 2 lots

Executed

Jan 29 2025

the trade date, as filed

Disclosed

Jan 31 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER profile →

Daniel Rabinowitz (SEC. AND CHIEF LEGAL OFFICER) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Natera, Inc. (NTRA). The largest single filing was $8.5M of NTRA (33,600 sh across 4 lots, as filed), executed Jun 24.

The name

NTRA

Natera, Inc. NTRA · Healthcare · 219 filings in 24 months ticker →

Healthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Daniel Rabinowitz in NTRA

NTRASALE Natera, Inc. $485K
1,887 sh across 2 lots
Exec Jul 27
Filed Jul 29 · 9:35 PM ET NTRASALE Natera, Inc. $4.5M
16,500 sh across 11 lots
Exec Jul 1
Filed Jul 6 · 9:05 PM ET NTRASALE Natera, Inc. $8.5M
33,600 sh across 4 lots
Exec Jun 24
Filed Jun 26 · 5:30 PM ET NTRASALE Natera, Inc. $380K
1,861 sh across 2 lots
Exec Apr 27
Filed Apr 29 · 5:30 PM ET NTRASALE Natera, Inc. $1.6M
8,100 sh across 4 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET NTRASALE Natera, Inc. $356K
1,745 sh × $204.13
Exec Mar 10
Filed Mar 11 · 5:30 PM ET NTRASALE Natera, Inc. $1.6M
7,998 sh across 4 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET NTRASALE Natera, Inc. $308K
1,334 sh × $230.77
Exec Feb 3
Filed Feb 4 · 5:30 PM ET